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Although in literature few successful claims have been shown in comparison with other medical specialties such as gynaecology
and orthopaedics, vascular surgery is included among high-risk specialties. The high-risk of receiving medical claims may lead
vascular surgeons to practice defensive medicine, as is normal in several other areas of clinical practice. No studies are available to
our knowledge of the incidence of defensive medicine in the field of vascular surgery. Taking into consideration the scarce amount
of information, the authors provide a critical discussion regarding the application of defensive medicine behaviour among vascular
surgeons.
1. Introduction
Defensive medicine has been defined as the practice of order-
ing tests, procedures, and visits or the practice of avoiding
treatments for patients considered at high-risk, in order to
prevent medical malpractice claims [1, 2]. In the last decades,
the culture of defensive medicine has grown worldwide
because of the ever increasing number of medical claims,
usually associated with high-risk medical areas [3]. As defen-
sive medicine is used among physicians in order to lessen
their exposure to medical malpractice litigation, this practice
is constantly growing in all medical specialties on the pre-
sumption that every patient may be a potential litigant. In the
course of time, defensive medicine has become a more and
more transversal practice, encompassing all medical areas.
A reduction of defensive medicine could help to improve
the quality of medical care delivered by hospitals and in all
medical specialties the diffusion of this phenomenon should
be better controlled. Vascular surgery is a specialty of surgery
in which diseases of the vascular system, or arteries and
veins, are managed by medical therapy, minimally invasive
catheter procedures, and surgical reconstruction. The spe-
cialty evolved from general and cardiac surgery as well as
minimally invasive techniques pioneered by interventional
radiology [1–3].
Although in literature a low incidence of successful
claims has been shown in comparison with other medical
specialties such as gynaecology and orthopaedics, vascular
surgery is included among the high-risk specialties. A high-
risk of receivingmedical claimsmay lead vascular surgeons to
practice defensive medicine, as in every other area of clinical
practice. Nevertheless, to our knowledge, no studies are
available in literature about the practice of defensivemedicine
in vascular surgery. The aim of this paper is to examine the
defensive approach, not only in its current application, but
also in the field of vascular surgery, discussing howbeing sued
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can affect medical treatment therefore highlighting the need
to assess the real incidence of certain defensive behaviours
among vascular surgeons.
2. Materials and Methods
The following databases (from 1978 to January 2015)Medline,
Cochrane Central, Scopus, Web of Science, and Science
Direct were used, searching with the following key words:
vascular surgery, defensive medicine, medical negligence,
andmisdiagnosis.Themain key word “vascular surgery” was
searched for singularly and then associated individually with
each of the other keywords.
Of the 446 sources found, only 22 were considered
appropriate for the purpose of this paper. All sources have
been screened independently by three physicians and in order
to be included they had to be selected by at least two of them.
3. Some Data about Defensive Medicine
Thephenomenon of defensive medicine adds 5% to 9% to the
cost of US medical care and the annual medical liability sys-
tem costs along with defensive practice have been estimated
in 2008 as $55.6 billion of dollars equal to 2.4% of total health
care spending [4, 5]. Recently, the Italian parliamentary board
of inquiry estimated the cost of defensive medicine in the
public sector at 10.5% while in the private sector it amounts
to 14% of total health care spending. Therefore, according to
the board, defensive medicine costs 10 billion euros, equal to
0.75% of the gross national product. Although several studies
have been published about various approaches to defensive
medicine, the consequences deriving from it are still con-
troversial and debatable [6]. Tancredi and Barondess [2], for
example, reported a comprehensive study supporting how
defensive medicine does not determine the increase of health
care costs but rather increases the exposure of patients toward
unnecessary risks. In the same way, defensive medicine has
been further defined as a widespread practice with little
impact on medical care costs [7]. Defensive medicine, as
reported by several clinical studies, has a negative impact
on the quality of medical care, even without taking into
consideration the price of this practice [8]. Several studies
have highlighted how lawsuits have a negative impact on
physicians causing them stress thereby jeopardizing their
future performance [9]. The increase of public attention
towards adverse events together with the patients’ expec-
tation in obtaining higher compensation for damage from
medical malpractice has created a significant pressure on
health professionals, making it more difficult for them to
obtain adequate insurance coverage, particularly in some
specialized branches (such as gynecology and orthopedics)
more exposed to this risk. Medical claims are clearly based
on the law of medical malpractice which still represents the
main guarantee for patients and a useful tool for protecting
the patients’ health. Although medical liability discourages
substandard care and allows patients to obtain reasonable
damage compensation, there is no evidence in the literature
that a fear of being sued is useful for reducing the rate
of medical error [10]. In this perspective, the increase of
exposure to medical malpractice has been making physicians
more careful and conscious of their own actions. Considering
a defensive approachwe can identify two different forms: pos-
itive and negative. While the positive form can be defined as
the practice of performing unnecessary therapeutic and diag-
nostic treatments, the negative form can be identified as the
practice of declining to providemedical care. Both in positive
and in negative form, the primary aim is to prevent medical
claims, rather than to promote the patient’s best interest [11].
4. Vascular Surgery between Defensive
Medicine and Medical Malpractice
The exposure to medical malpractice litigation has also
increased in the field of vascular surgery, where physicians
are called to cure disorders affecting arteries, veins, and
lymph vessels. As for every other area of clinical practice,
vascular surgeons tend to be sued for failing to deliver safe
and appropriate care to patients [12]. Physicians involved in
vascular surgery may be sued when the execution of surgical
treatments or preoperative activities (diagnostic procedures)
are the result of medical malpractice. Because vascular
surgeons are also frequently involved in other surgical treat-
ments (elected for different reasons), due to intraoperative
complications such as bleeding disorders, in examining the
phenomenon of defensive medicine the general division
between general and vascular surgery could be misleading. A
study conducted by Campbell et al. [13] in England involving
424 claims revealed that varicose vein is the most common
pathology involved in medical claims and nerve damage
was the most frequent subject of complaints, followed by
incorrect surgery and damage to the femoral vein and artery.
Markides et al. in 2008 found that 50% of all successful claims
were based on intraoperative problems, while 14% and 11%
were assigned, respectively, to failure/delay of treatment and
diagnosis. Varicose vein surgery was identified as the most
common area of litigation, followed by peripheral vascular
disease and abdominal aortic aneurysm. Both the studies
above mentioned highlight the prevalence of varicose vein
surgery in the management of medical claims regarding
vascular surgery, taking into consideration that other diseases
such as intraoperative nerve and vessel damage may cause
worse permanent damage to the patient [14].
5. Discussion
The probability of defensive performances, among physi-
cians, is directly proportional to the specific risk level. Among
surgical specialties, vascular surgery is considered to be a
high-risk of litigation as confirmed by Jena et al. [15] in a
study of 2011, where the proportion of physicians dealing
with malpractice claims has been evaluated taking into
consideration each specialty. The results obtained show an
almost 19% per year probability of facing a claim for vas-
cular surgeons together with thoracic and cardiac surgeons
[15]. Nevertheless, no study has yet been conducted in the
literature about the incidence of defensive medicine in the
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specific field of vascular surgery. The exposure of vascular
surgeons to medical malpractice litigation may be relevant
both in emergency and in elective surgery, where the control
of unexpected intraoperative bleeding may differently affect
the physicians’ performance. “Type of treatment” and “time
factor” may also represent two important key points in the
evaluation of defensive approaches among vascular surgeons.
Reporting the main types of disease and procedures involved
in successful medical claims recorded by the NHS Litigation
Authority, Markides et al. highlighted the importance of a
correct and appropriate treatment in the management of
patients with peripheral vascular disease (PVD), abdominal
aortic aneurysm (AAA), and carotid artery disease (CAD)
[14]. The main issue involving vascular surgeons is due to
the management of CAD and the probability of causing
serious neurological damage (e.g., ictus) or, in the worst
case, the death of the patient, posing an interesting question
whether or not vascular surgeons should operate on patients
with asymptomatic carotid stenosis. The proper treatment
of carotid stenosis has always been of great interest for
the vascular surgeons. In order to standardize the approach
to this pathology, the Society for Vascular Surgery (SVS)
published in 2008 specific guidelines for the treatment of
carotid stenosis, providing recommendations on the basis
of an evidence-based medicine approach [16, 17]. According
to these guidelines, recommendations for medical therapy
rather than surgical treatment depend on the grade of carotid
stenosis, distinguishing among patients with a low, moderate,
and severe grade of carotid stenosis. In this perspective, prac-
tical examples of positive defensive approaches with the aim
of preventing medical claims in case of ictus or death should
only be not following specific guidelines and performing sur-
gical treatment without specific symptoms, together with an
overestimation of diagnostic test results (e.g., Eco-Doppler),
thereby exposing the patients to unnecessary surgery.
Further aspects should be considered in the occurrence
of mistakes in surgical procedures. An interesting approach
is the evaluation of “time factor” in vascular surgery, carried
out by Sirignano et al, who highlighted, between 2009 and
2011, 63 claims involving vascular procedures and how the
erroneous timing in surgical, medical, or diagnostic inter-
vention may generate errors and how even more frequently
errors occur in cases treated electively rather than in urgent
or emergency cases [18].
An “emblematic” question may arise in the evaluation
of erroneous timing in vascular surgery: which factors can
affect the timing of elective procedures? In this perspective a
useful support in the attempt to provide a valid answer is to
underline the role of “defensivemedicine,” which still remains
controversial. A “positive” defensive medicine approach can
occur in the assessment of “cardiac risk stratification” for
vascular surgery, which is considered a very high-risk cate-
gory, associated with cardiac morbidity rates greater than 5%
in many reports. Examples include aortic and other major
vascular surgeries, as well as peripheral vascular surgery [19].
For this reason, in order to avoid underestimation of the
cardiac risk, vascular surgeons may assume an “assurance
behavior,” which increases the time of preoperative investi-
gation with economic repercussions.
With the aim of reducing this phenomenon, the guide-
lines of the American Association College of Cardiology
and the American Heart Association recommend preoper-
ative cardiac testing only when the results may influence
patients’ management. Moreover, they individuated four
high-risk conditions, showing how to assess and treat them
preoperatively; they include unstable coronary syndromes,
decompensated heart failure, significant cardiac arrhythmias,
and severe valvular disease. Applying these guidelines in
an appropriate manner could help in reducing the risks of
incurring in medical defensive procedures.
If, on the one hand, the application of positive defense
medicine in vascular surgery can impact on the consequences
above reported, on the other hand, the effects of negative
defense medicine can be even more dangerous, as it is based
on “avoidance behaviors” only with the aim of reducing
the risk of litigation in certain medical activities. However,
according to data reported below, this attitude may some-
times increase the number of claims.The authors of the same
study [18] have also tried to evaluate the “time factor” and
how it can affect the final outcome in patient treatment.
In a paper of 2012 [18] five cases of claims in vascular
surgery, in which the “time factor” played a key role in
delaying or in not performing a surgical procedure, were
reported. In one case, the delay in performing the ligation
of an arteriovenous fistula in the left arm of a 75-year-old
woman undergoing haemodialysis, which was diagnosed in
September and not operated on until the next December due
to numerous follow-up visits, caused a severe bleeding in
the arm and the death of the patient shortly after. Another
case involved a 63-year-old male, who after an intervention
of saphenectomy complained of a severe pain in his foot,
which was not treated causing, on the 4th postoperative day,
the amputation of the leg, for a severe ischemia of the foot
due to a thrombosis of popliteal and tibial arteries. Because
amputation of a limb is a drastic solution, intolerable for a
patient to take into consideration even if suffering from critic
ischemia, a therapeutic approach based on an excessive use of
revascularization therapies aiming only to obtain a defense in
a potential lawsuit is another pragmatic example of positive
defensive medicine.
Other important issues worthy of attention, which should
be evaluated, are the different medico-legal implications of
endovascular versus open surgery and the peculiar features of
vascular surgery from the perspective of defensive medicine
and the consequent medico-legal problems that may result.
Regarding the first aspect, over the past 30 years, vascular
surgery has undergone a significant evolution process: all has
changed with the advent of endovascular procedures and,
thanks to the rapid evolution of available grafts, everything
is still changing. The approach to patients has varied as well
as indications. Critically impaired patients, in poor general
condition, can be subjected to effective treatments that were
not first to be proposed for the high-risks associated with
open surgery [20]. The availability of those new “less inva-
sive” endovascular procedures could have influenced some
“inexperienced” surgeons of the existence of an easier way to
treat patients. However, this assumption has to be considered
wrong.Thenew endovascular procedures represent, together,
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Table 1: Vascular surgery pathologies: carotid stenosis, aortic aneurysms, aortic dissections, and peripheral arterial disease, evaluated in the
light of the indication, timing, and technique.
Indication Timing Techniques
Carotid stenosis
To treat symptomatic stenosis or
only haemodynamic asymptomatic
lesions
Within 24 hours from symptoms
onset or within 14 days
Carotid endarterectomy or carotid
artery stenting
Aortic aneurysms
To treat on the basis of the diameter
or on the basis of accompanying
symptoms and/or aortic
morphology
In case of symptoms: as soon as
possible or after careful patient
evaluation
Open repair or endovascular repair
Aortic dissections
To treat all the dissection or
selectively on the basis of visceral
malperfusion, aneurismatic
dilatation, and uncontrolled pain
and hypertension
Within 15 days from symptoms
onset or after 15 days Open repair or endovascular repair
Peripheral arterial
disease
To treat patients presenting with
claudication or only patients with
critical limb ischemia
Critical limb ischemia presenting
patient should always be treated in
urgent/emergent setting
Open repair or endovascular repair.
In case of endovascular repair, use
or do not use stent, covered stent,
and drug eluting devices
To recognize patients presenting
with acute limb ischemia
a very efficient weapon for the clinician but for an experi-
enced clinician, at the end of an adequate learning curve.
A modern vascular surgeon must be a surgeon, capable of
working with the same skills in both open and endovascular
surgical procedures [21].
Finally, in considering the fields of application of vascular
surgery from the perspective of defensive medicine and the
consequent medico-legal problems that may result, three
key aspects have to be carefully evaluated: the indication,
the timing, and the technique used; in Table 1 are reported
four pathologies of vascular surgery: carotid stenosis, aortic
aneurysms, aortic dissections, and peripheral arterial disease,
which are evaluated in the light of the three indicators above
mentioned [20, 21].
6. Conclusions
In conclusion, the little literature available about defensive
medicine related to vascular surgery leads us to take seriously
into consideration the need to assess the real incidence
of defensive medicine in this area. In order to assess the
current trend of defensive medicine (positive and negative)
in vascular surgery, we suggest focusing not only on the
personal perceptions of vascular surgeons practicing it, which
however could be underestimated taking into account “avoid-
ance behaviors,” but also on reporting and reevaluating any
suspicious case with a team of specialist surgeons, who can
evaluate all diagnostic and surgical procedures undertaken
together with the compliance to the guidelines and runtimes.
Only in this way will it be possible to have a true picture of
this phenomenon and therefore be able to correct the negative
impact it has in terms of cost and quality on the health service.
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